Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Gwyneth Soon, Aileen Wee
Clin Mol Hepatol. 2021;27(1):44-57.   Published online 2020 Nov 19     DOI: https://doi.org/10.3350/cmh.2020.0181
Citations to this article as recorded by Crossref logo
Noninvasive surrogates are poor predictors of liver fibrosis in patients with Fontan circulation
Yu Rim Shin, Seung Up Kim, Sak Lee, Jae Young Choi, Han Ki Park, Jeong Eun Yoo, Young Nyun Park
The Journal of Thoracic and Cardiovascular Surgery.2022; 164(4): 1176.     CrossRef
Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jae Young Jang, Soo Young Park, Hyun Woong Lee, Chun Kyon Lee, Seung Up Kim
Frontiers in Medicine.2022;[Epub]     CrossRef
Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH
Nikolai V. Naoumov, Dominique Brees, Juergen Loeffler, Elaine Chng, Yayun Ren, Patricia Lopez, Dean Tai, Sophie Lamle, Arun J. Sanyal
Journal of Hepatology.2022; 77(5): 1399.     CrossRef
The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
Haofei Hu, Yong Han, Changchun Cao, Yongcheng He
Journal of Translational Medicine.2022;[Epub]     CrossRef
Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
Beom Kyung Kim, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Tuo Lin, Xin M. Tu, Jaclyn Bergstrom, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi N
Journal of Hepatology.2022; 77(6): 1482.     CrossRef
Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease
Han Ah Lee, Seung-seob Kim, Jin-Young Choi, Yeon Seok Seo, Beom Jin Park, Ki Choon Sim, Seung Up Kim
Abdominal Radiology.2022; 47(11): 3733.     CrossRef
Rethinking Liver Fibrosis Staging in Patients with Hepatocellular Carcinoma: New Insights from a Large Two-Center Cohort Study
Wei Xu, Bolun Li, Zhanwei Yang, Jingdong Li, Fei Liu, Yu Liu
Journal of Hepatocellular Carcinoma.2022; Volume 9: 751.     CrossRef
NAFLD, MAFLD and obesity: brothers in arms?
Mariana Verdelho Machado, Helena Cortez-Pinto
Nature Reviews Gastroenterology & Hepatology.2022;[Epub]     CrossRef
Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
Ludovico Abenavoli, Tiziana Larussa, Alessandro Corea, Anna Caterina Procopio, Luigi Boccuto, Marcello Dallio, Alessandro Federico, Francesco Luzza
Nutrients.2021; 13(2): 494.     CrossRef
The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics
James Neuberger, Owen Cain
Hepatic Medicine: Evidence and Research.2021; Volume 13: 59.     CrossRef
Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
Hee Kyung Shin, Jeong Hwan Park, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Jin-Woo Lee, Won Kim
Scientific Reports.2021;[Epub]     CrossRef
Predict Early Recurrence of Resectable Hepatocellular Carcinoma Using Multi-Dimensional Artificial Intelligence Analysis of Liver Fibrosis
I-Ting Liu, Chia-Sheng Yen, Wen-Lung Wang, Hung-Wen Tsai, Chang-Yao Chu, Ming-Yu Chang, Ya-Fu Hou, Chia-Jui Yen
Cancers.2021; 13(21): 5323.     CrossRef
Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspring
Michael J. Nash, Evgenia Dobrinskikh, Sean A. Newsom, Ilhem Messaoudi, Rachel C. Janssen, Kjersti M. Aagaard, Carrie E. McCurdy, Maureen Gannon, Paul Kievit, Jacob E. Friedman, Stephanie R. Wesolowski
JCI Insight.2021;[Epub]     CrossRef